005250.KS
Green Cross Holdings Corporation
KSC · Healthcare · Biotechnology · KR
KRW 9,850.00
+0.00%Year over year
Reported trailing growth
- Revenue
- +9.6%
- EBITDA
- -65.7%
- EBIT
- +8.6%
- EPS
- —
- Free cash flow
- +108.8%
- Operating cash flow
- +204.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +5.6%
- EBITDA
- -7.6%
- EBIT
- -21.4%
- Net income
- —
- EPS
- —
- Free cash flow
- +41.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026